Pilot Trial Investigating Fermented Whey Supplementation in Healthy Adults

University of Aberdeen

Status: Completed

Conditions: Healthy

Treatments: Dietary Supplement: Molkosan

Study type: Interventional

Funder types: Other

Identifiers

NCT03615339

799

Details and patient eligibility

About

Pilot trial: 6-week single arm intervention. Healthy adults (male and female) consume Molkosan (fermented whey) twice a day (AM & PM).

Full description

Molkosan® is made from fresh organic whey using a special fermentation process involving lactic acid producing bacteria (L+ lactic acid 70g/L). The company, A.Vogel (Roggwil, Switzerland) will provide the product and we will collect biological samples for analysis in a proof of concept study design that will provide preliminary data for future larger studies.

Enrollment: 22 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• age 18-65
• BMI 18-40 kg/m-2

Exclusion criteria

• Diabetes
• Severe gastrointestinal disorders,
• Kidney disease,
• Thromboembolic or coagulation disease,
• Hepatic disease,
• Alcohol or any other substance abuse
• Gout
• Eating disorders
• Unregulated thyroid disease
• Dairy intolerance
• Antibiotic use within the last 3 months, including prescribed use
• Current prebiotic or prebiotic use

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

22 participants in 1 patient group

Molkosan

Experimental group

Description:

Consumption of Molkosan (fermented whey) 20ml to be diluted in 200ml water prior to use twice a day (morning \& evening). Total duration was 6 weeks.

Treatment:

Dietary Supplement: Molkosan